Stock 4743 ONENESS BIOTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Oneness Biotech Co., Ltd.

Equities

4743

TW0004743000

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
159 TWD +3.92% Intraday chart for Oneness Biotech Co., Ltd. +6.71% -18.25%
Mar. 29 Oneness Biotech Co., Ltd. Announces Submission of A Phase II Clinical Trial Protocol to Taiwan FDA for Subcutaneous Injection Formulation ofFB825 in Patients with Moderate-To-Severe Atopic Dermatitis CI
Mar. 11 Oneness Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

ONENESS BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include health supplies, health food and healthy food. The Company is also involved in the development of new drugs for the treatment of wound healing in chronic diabetic foot ulcers, as well as the development of new anticancer drugs. The Company distributes its products in domestic market.

Number of employees: 43

Sales per Business

TWD in Million2022Weight2023Weight Delta
New Drug Research and Development
83.6 %
1,039 97.5 % 73 83.6 % -93.01%
Cultivation of Agricultural Products
28.6 %
39 3.6 % 25 28.6 % -35.96%
Reconciling Items
-12.2 %
-12 -1.1 % -11 -12.2 % -11.96%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
1,066 100.0 % 87 100.0 % -91.86%

Managers

Managers TitleAgeSince
Shan Nei Huang CEO
 Chief Executive Officer 80 15-06-25
Chih Hui Cheng CEO
 Chief Executive Officer - 18-06-20
Wen Tzu Hsiao DFI
 Director of Finance/CFO - 19-09-30
Tzu Chun Yang CTO
 Chief Tech/Sci/R&D Officer - 19-08-31
Yueh Ju Wang CTO
 Chief Tech/Sci/R&D Officer - 18-02-28
Nien Yi Chen CTO
 Chief Tech/Sci/R&D Officer - 19-07-31

Members of the board

Members of the board TitleAgeSince
Chih Hui Cheng CEO
 Chief Executive Officer - 18-06-20
Hsien Shou Kuo BRD
 Director/Board Member 82 10-04-25
Shih Hua Hsu BRD
 Director/Board Member - 12-06-26
Jui Wen Huang BRD
 Director/Board Member - 15-06-25
Shan Nei Huang CEO
 Chief Executive Officer 80 15-06-25
Sui Lu BRD
 Director/Board Member - 18-06-20
San Kuei Huang BRD
 Director/Board Member - 21-08-17
Rey Yuh Wu BRD
 Director/Board Member - 21-08-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 454,547,179 317,309,179 ( 69.81 %) 984,000 ( 0.2165 %) 69.81 %

Shareholders

NameEquities%Valuation
MICROBIO CO., LTD.
19.68 %
89,472,699 19.68 % 491 M NT$
State Street Global Advisors Ltd.
0.1821 %
827,922 0.1821 % 5 M NT$
Chih Hui Cheng
0.1416 %
643,760 0.1416 % 4 M NT$
First Securities Investment Trust Co. Ltd.
0.0392 %
178,223 0.0392 % 977 336 NT$
Storebrand Asset Management AS
0.006432 %
29,236 0.006432 % 160 324 NT$
Mercer Global Investments Europe Ltd.
0.005256 %
23,892 0.005256 % 131 018 NT$
Dimensional Fund Advisors Ltd.
0.001883 %
8,560 0.001883 % 46 941 NT$
State Street Global Advisors Ltd. (Canada)
0.000751 %
3,413 0.000751 % 18 716 NT$
Irish Life Investment Managers Ltd.
0.000500 %
2,275 0.000500 % 12 476 NT$
DFA Australia Ltd.
0.000493 %
2,242 0.000493 % 12 295 NT$

Holdings

NameEquities%Valuation
DIAMOND BIOFUND INC.
14.05%
 119,400,289 14.05% 156,322,440 $

Company contact information

Oneness Biotech Co., Ltd.

11st Floor No. 236, Section 4, Xinyi Road

106, Taipei

+886 2 2703 1098

http://www.onenessbio.com.tw
address Oneness Biotech Co., Ltd.(4743)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Oneness Biotech Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
159 TWD
Average target price
262 TWD
Spread / Average Target
+64.78%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ONENESS BIOTECH CO., LTD. Stock Oneness Biotech Co., Ltd.
-18.25% 2.21B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 664B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 567B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 234B
NOVARTIS AG Stock Novartis AG
+4.71% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 196B
AMGEN INC. Stock Amgen Inc.
-4.04% 148B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4743 Stock
  4. Company Oneness Biotech Co., Ltd.